Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform

Silo Pharma announced that its subsidiary QwikAgents has joined AMD’s AI Developer Program, gaining access to AMD Developer Cloud credits, AI tools, training, and technical resources. The company says the program will help accelerate development, testing, optimization, benchmarking, and potential training of its enterprise AI agent platform. QwikAgents is being positioned as a persistent AI-agent platform for individuals, developers, small businesses, and enterprises, with use cases including research, content generation, scheduling, coding, browser automation, and workflow automation. The partnership is framed as a technology-enablement move rather than a direct revenue event, but it could improve Silo’s AI product development cadence and broaden investor attention toward its non-biotech initiatives. The release did not include financial guidance or immediate commercialization data, so market impact is likely limited to sentiment around strategic AI collaboration.